Trident Lifeline

284.00
0.00
(0.00%)
Market Cap
326.60 Cr
EPS
5.52
PE Ratio
32.02
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
339.00
52 Week Low
140.05
PB Ratio
5.67
Debt to Equity
0.26
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,787.40
#1 4,28,857.13
36.71
#1 49,887.20
12.06
#1 9,648
13.77
59.27
6,012.50
1,59,612.98
79.83
8,184.00
0.89
1,600
#1 64.53
57.99
1,525.90
1,23,233.96
25.11
26,520.70
14.17
4,155
47.38
57.43
3,238.90
1,09,619.09
60.42
10,785.70
11.59
1,656
13.54
52.37
2,557.50
1,05,516.96
52.60
10,615.60
19.57
1,942
-16.38
59.98
1,174.80
98,031.82
#1 18.66
28,905.40
12.36
5,578
1.69
54.12
2,019.60
92,203.01
33.50
20,141.50
#1 19.94
1,936
38.82
50.28
859.65
86,500.90
19.53
19,831.50
13.82
3,831
29.92
46.44
1,220.10
70,863.61
20.72
29,559.20
17.55
3,169
-10.04
58.85
29,705.00
63,121.05
47.82
6,097.20
10.80
1,201
16.01
45.94
Growth Rate
Revenue Growth
41.95 %
Net Income Growth
-1.67 %
Cash Flow Change
111.74 %
ROE
-13.85 %
ROCE
0.80 %
EBITDA Margin (Avg.)
-2.53 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
9
6
8
10
9
9
10
7
21
14
16
12
Expenses
7
5
6
7
7
7
8
6
17
11
11
8
EBITDA
2
1
2
2
3
2
3
2
4
4
5
5
Operating Profit %
20 %
14 %
18 %
21 %
23 %
20 %
22 %
20 %
12 %
19 %
26 %
34 %
Depreciation
0
0
0
0
0
0
0
0
0
1
0
1
Interest
0
0
0
0
0
0
0
0
0
1
1
1
Profit Before Tax
2
1
2
2
2
2
2
1
3
3
4
4
Tax
-1
0
0
0
0
1
1
0
1
1
1
1
Net Profit
3
1
1
2
2
1
2
1
2
2
3
3
EPS in ₹
15.02
0.88
1.15
1.77
1.72
1.22
1.48
0.94
1.41
1.39
2.69
2.42

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
14
63
87
Fixed Assets
1
3
21
Current Assets
11
49
52
Capital Work in Progress
0
5
4
Investments
0
0
0
Other Assets
12
55
62
Total Liabilities
14
63
87
Current Liabilities
8
12
20
Non Current Liabilities
2
4
13
Total Equity
5
47
54
Reserve & Surplus
-3
34
40
Share Capital
8
12
12

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
0
14
-7
Investing Activities
-0
-10
-20
Operating Activities
-0
-19
2
Financing Activities
1
42
11

Share Holding

% Holding
Aug 2022
Sept 2022
Oct 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
100.00 %
69.57 %
69.57 %
69.85 %
69.99 %
70.04 %
70.04 %
70.04 %
67.48 %
65.51 %
62.99 %
62.99 %
63.04 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
4.64 %
6.02 %
6.02 %
6.09 %
6.09 %
6.62 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.09 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
23.18 %
23.18 %
15.13 %
13.38 %
14.30 %
14.82 %
14.43 %
16.39 %
18.37 %
19.40 %
18.90 %
18.26 %
Others
0.00 %
7.25 %
7.25 %
15.02 %
16.63 %
15.66 %
15.14 %
10.88 %
10.10 %
10.10 %
11.52 %
12.02 %
11.99 %
No of Share Holders
0
10
1,389
397
388
387
439
481
500
502
507
523
534

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Half Year And Year Ended 31St March 20254 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Shareholders Meeting-EGM-09-05-20259 days ago
Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 20159 days ago
Announcement under Regulation 30 (LODR)-Issue of Securities10 days ago
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association10 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. 16.04.202510 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Board Meeting Intimation for Consider And Approve The Proposal To Raise Funds At The Board Meeting To Be Held On April 16 2025Apr 09, 2025
Closure of Trading WindowMar 31, 2025
Disclosure Under Regulation 30 Of LODR- Cessation Of Step-Down Subsidiary CompanyMar 27, 2025
Board Meeting Outcome for Outcome Of Separate Meeting Of Independent DirectorsMar 26, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 19, 2025
Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015Mar 19, 2025
Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011Mar 19, 2025
Intimation Pursuant To Regulation 30 - Corporate GuaranteeMar 12, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsMar 05, 2025
Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015Mar 05, 2025
Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011Mar 05, 2025
Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015Mar 05, 2025
Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011Mar 05, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 05, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 05, 2025
Intimation Pursuant To Regulation 30 - Corporate GuaranteeFeb 25, 2025
Intimation Pursuant To Regulation 30 - Corporate GuaranteeFeb 25, 2025
Intimation Pursuant To Regulation 30 - Corporate GuaranteeFeb 14, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionFeb 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 24, 2025
Integrated Filing (Financial)Jan 22, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 22, 2025
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter Ended 31St December 2024.Jan 22, 2025
Result-Financial Result For The Quarter And Nine Months Ended December 31 2024Jan 22, 2025
Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Nine Months Ended 31St December 2024Jan 22, 2025
Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For Quarter Ended 31St December 2024Jan 16, 2025
Intimation Of Change Of Name Of Registrar And Share Transfer Agent Of The Company.Jan 02, 2025
Closure of Trading WindowDec 30, 2024
Announcement under Regulation 30 (LODR)-AcquisitionDec 23, 2024
Outcome Of Board MeetingDec 23, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On December 23 2024Dec 23, 2024
Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 02, 2024
Announcement under Regulation 30 (LODR)-AcquisitionNov 26, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On November 26, 2024Nov 26, 2024
Outcome Of Board MeetingNov 26, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 25, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 21, 2024
Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligation & Disclosures Requirements) Regulation, 2015 For The Half Year Ended 30Th September, 2024Oct 19, 2024
Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 30Th September, 2024.Oct 19, 2024
Result-Financial Result For The Half Year Ended On September 30, 2024Oct 19, 2024
Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Half Year Ended 30Th September, 2024.Oct 19, 2024
Board Meeting Intimation for Consider And Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Half Year Ended On September 30, 2024Oct 15, 2024

Technical Indicators

RSI(14)
Neutral
62.48
ATR(14)
Volatile
15.07
STOCH(9,6)
Neutral
74.87
STOCH RSI(14)
Overbought
85.80
MACD(12,26)
Bullish
1.97
ADX(14)
Weak Trend
18.14
UO(9)
Bearish
55.69
ROC(12)
Uptrend And Accelerating
10.42
WillR(14)
Overbought
-8.83